Table 2.
Country/Region | App | Type of App | Impact | References |
---|---|---|---|---|
Australia | COVIDSafe | tracing |
epidemiological surveillance, date, time and duration of contact user data privacy concerns, lack of trust, ethical issues, security vulnerabilities, technical constraints |
[147,148] |
France | StopCovid | |||
TousAntiCovid | ||||
Germany | Corona-Warn-App | |||
Globally | TraceTogether | |||
COVID Trace | ||||
NOVID Share Trace Safe2 |
the user receives a unique ID, and at the time of infection, he is redirected to medical applications | [149] | ||
Italy | Immuni |
epidemiological surveillance, date, time, and duration of contact user data privacy concerns, lack of trust, ethical issues, security vulnerabilities, technical constraints |
[147,148] | |
Spain | AsistenciaCOVID-19 | |||
Switzerland | SwissCovid | |||
Globally | HowWeFeel | medical |
for health care professionals and researchers; a useful tool for patients, quarantine advice, and measures to ensure well-being. The authorized access was ensured by firewalls, antiviruses, and cryptographic algorithms |
[149] |
Mexico | Sofia |
video consultations: internal medicine and pediatric consultations, prescriptions, follow-up indications; high levels of patient satisfaction, versatile and convenient tool to manage the situation |
[150] | |
USA | Teladoc | access to low-cost and high-quality doctors, clinical expertise, virtual care for consumers and clinicians | [151] |
The limitations refer to mobile device ownership or accessibility to mobile apps, network connection problems, misdiagnosis of C19, or app takeover by the pharmaceutical industry [152].